Please wait...

Learn

Finding accredited CPD

Australasian College of Dermatologists 2026 Conference Review

Description

This is a summary of the Australasian College of Dermatologists ASM 2026 Conference Review which was held in Melbourne, earlier this year.

Selection and review of the research has been carried out independently by Dr Philip Tong.


Details

In this edition we feature:
 
-  Deucravacitinib & acneiform eruptions
-  Upadacitinib: long-term safety in atopic dermatitis with CV risk
-  T helper cell polarisation in checkpoint blockade-related cutaneous toxicities
-  Pre-dupilumab infectious disease screening in Australia
-  Microplastic exposure & keratinocyte biology
-  Melanomas in patients with Asian ancestry
-  3D total body photography + AI for melanoma risk stratification
-  AI controversies in dermatology
-  Scientific evidence on isotretinoin controversies
-  Updates in sunscreen research
 

To access this publication please click ‘Enrol Now’ and you’ll be directed to  the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website. 

Provided by


CPD Activity Details
Topic
General Medicine, Dermatology
CAPE Aspects
_
Effective Year

Educational Activities (EA) - 0.30

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s Registration Standard: Continuing professional development (the Standard)